These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26220901)

  • 1. Plant alkaloids as drug leads for Alzheimer's disease.
    Ng YP; Or TC; Ip NY
    Neurochem Int; 2015 Oct; 89():260-70. PubMed ID: 26220901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkaloids as drug leads in Alzheimer's treatment: Mechanistic and therapeutic insights.
    Rezaul Islam M; Akash S; Murshedul Islam M; Sarkar N; Kumer A; Chakraborty S; Dhama K; Ahmed Al-Shaeri M; Anwar Y; Wilairatana P; Rauf A; Halawani IF; Alzahrani FM; Khan H
    Brain Res; 2024 Jul; 1834():148886. PubMed ID: 38582413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
    Sahoo AK; Dandapat J; Dash UC; Kanhar S
    J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-cholinergic alkaloids as potential therapeutic agents for Alzheimer's disease: an in silico approach.
    Naaz H; Singh S; Pandey VP; Singh P; Dwivedi UN
    Indian J Biochem Biophys; 2013 Apr; 50(2):120-5. PubMed ID: 23720886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the therapeutic potential of steroidal alkaloids in managing Alzheimer's disease.
    Pandey PP; Kumar MS
    Steroids; 2024 Sep; 209():109468. PubMed ID: 38959993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease.
    Konrath EL; Passos Cdos S; Klein LC; Henriques AT
    J Pharm Pharmacol; 2013 Dec; 65(12):1701-25. PubMed ID: 24236981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer's Disease.
    Vrabec R; Blunden G; Cahlíková L
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of phytochemicals in the treatment and prevention of dementia.
    Howes MJ; Perry E
    Drugs Aging; 2011 Jun; 28(6):439-68. PubMed ID: 21639405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Therapeutic Strategies for Dementia.
    Cacabelos R; Torrellas C; Carrera I; Cacabelos P; Corzo L; Fernández-Novoa L; Tellado I; Carril JC; Aliev G
    CNS Neurol Disord Drug Targets; 2016; 15(2):141-241. PubMed ID: 26831267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multitarget drugs of plants origin acting on Alzheimer's disease.
    Russo P; Frustaci A; Del Bufalo A; Fini M; Cesario A
    Curr Med Chem; 2013; 20(13):1686-93. PubMed ID: 23410167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huperzine a as potential treatment of Alzheimer's disease: an assessment on chemistry, pharmacology, and clinical studies.
    Ha GT; Wong RK; Zhang Y
    Chem Biodivers; 2011 Jul; 8(7):1189-204. PubMed ID: 21766442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential therapeutic agents against Alzheimer's disease from natural sources.
    Park SY
    Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current pharmacotherapy for Alzheimer's disease.
    Lleó A; Greenberg SM; Growdon JH
    Annu Rev Med; 2006; 57():513-33. PubMed ID: 16409164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease, enzyme targets and drug discovery struggles: from natural products to drug prototypes.
    Silva T; Reis J; Teixeira J; Borges F
    Ageing Res Rev; 2014 May; 15():116-45. PubMed ID: 24726823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ regulation-based multitarget strategy for drug discovery against Alzheimer's disease.
    Guo X; Jiang W; Li C; Zhu Z; Shen X
    Rev Neurosci; 2015; 26(1):13-30. PubMed ID: 25720054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutics of Alzheimer's disease: Past, present and future.
    Anand R; Gill KD; Mahdi AA
    Neuropharmacology; 2014 Jan; 76 Pt A():27-50. PubMed ID: 23891641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huperzia quadrifariata and Huperzia reflexa alkaloids inhibit acetylcholinesterase activity in vivo in mice brain.
    Konrath EL; Neves BM; Passos Cdos S; Lunardi PS; Ortega MG; Cabrera JL; Gonçalves CA; Henriques AT
    Phytomedicine; 2012 Nov; 19(14):1321-4. PubMed ID: 23022390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Neuroinflammation as a Therapeutic Strategy for Alzheimer's Disease: Mechanisms, Drug Candidates, and New Opportunities.
    Fu WY; Wang X; Ip NY
    ACS Chem Neurosci; 2019 Feb; 10(2):872-879. PubMed ID: 30221933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal Application of the Galantamine Pro-drug Memogain Slows Down Plaque Deposition and Ameliorates Behavior in 5X Familial Alzheimer's Disease Mice.
    Bhattacharya S; Maelicke A; Montag D
    J Alzheimers Dis; 2015; 46(1):123-36. PubMed ID: 25720404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.